Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
- PMID: 36318965
- PMCID: PMC10070067
- DOI: 10.1093/rheumatology/keac558
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Keywords: DMARDs; biologics; breastfeeding; breastmilk; corticosteroids; hydroxychloroquine; pregnancy; prescribing; rheumatic disease.
Figures
References
-
- Flint J, Panchal S, Hurrell A. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology 2016;55:1693–7. - PubMed
-
- Flint J, Panchal S, Hurrell A. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology 2016;55:1698–702. - PubMed
-
- Giles I, Allen A, Crossley A. et al. Prescribing anti-rheumatic drugs in pregnancy and breastfeeding - the BSR guideline scope. Rheumatology 2021;60:3565–9. - PubMed
-
- Gotestam Skorpen C, Hoeltzenbein M, Tincani A. et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75:795–810. - PubMed